2024 Q2 Form 10-Q Financial Statement

#000170569624000080 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $957.0M $951.5M
YoY Change 6.55% 8.41%
Cost Of Revenue $6.813M $6.511M
YoY Change 3.38% 9.39%
Gross Profit $950.2M $945.0M
YoY Change 6.58% 8.41%
Gross Profit Margin 99.29% 99.32%
Selling, General & Admin $15.77M $16.19M
YoY Change 5.68% 7.91%
% of Gross Profit 1.66% 1.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $992.0K $1.133M
YoY Change 11.84% 39.19%
% of Gross Profit 0.1% 0.12%
Operating Expenses -$6.917M $143.6M
YoY Change -1.51% -1.43%
Operating Profit $957.1M $801.4M
YoY Change 6.51% 10.38%
Interest Expense -$200.9M $204.9M
YoY Change 3.36% 0.26%
% of Operating Profit -20.99% 25.57%
Other Income/Expense, Net $19.32M $19.31M
YoY Change 4.31% 5.31%
Pretax Income $756.0M $601.4M
YoY Change 7.46% 13.69%
Income Tax $3.234M $1.562M
% Of Pretax Income 0.43% 0.26%
Net Earnings $741.3M $590.0M
YoY Change 7.33% 13.74%
Net Earnings / Revenue 77.46% 62.01%
Basic Earnings Per Share $0.71 $0.57
Diluted Earnings Per Share $0.71 $0.57
COMMON SHARES
Basic Shares Outstanding 1.043B shares 1.043B shares
Diluted Shares Outstanding 1.043B shares 1.043B shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $347.2M $485.3M
YoY Change -53.01% 95.95%
Cash & Equivalents $347.2M $485.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $347.2M $485.3M
YoY Change -53.01% 95.95%
LONG-TERM ASSETS
Property, Plant & Equipment $69.91M $68.24M
YoY Change -93.2% 1.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.461B $1.255B
YoY Change 132.95%
Other Assets $36.53M $35.97M
YoY Change 13.91% 5.11%
Total Long-Term Assets $44.16B $43.67B
YoY Change 6.39% 4.97%
TOTAL ASSETS
Total Short-Term Assets $347.2M $485.3M
Total Long-Term Assets $44.16B $43.67B
Total Assets $44.51B $44.16B
YoY Change 5.35% 5.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $256.9M $223.2M
YoY Change 1.83% -15.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $49.40M
YoY Change
Total Short-Term Liabilities $694.7M $710.3M
YoY Change 6.91% 7.48%
LONG-TERM LIABILITIES
Long-Term Debt $17.59B $17.53B
YoY Change 1.06% 0.79%
Other Long-Term Liabilities $92.55M $96.21M
YoY Change -10.25% -21.41%
Total Long-Term Liabilities $17.69B $17.62B
YoY Change 0.99% 0.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $694.7M $710.3M
Total Long-Term Liabilities $17.69B $17.62B
Total Liabilities $18.38B $18.34B
YoY Change -0.8% 0.89%
SHAREHOLDERS EQUITY
Retained Earnings $1.431B $1.123B
YoY Change 176.27% 409.81%
Common Stock $10.43M $10.43M
YoY Change 3.55% 3.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.72B $25.41B
YoY Change
Total Liabilities & Shareholders Equity $44.51B $44.16B
YoY Change 5.35% 5.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $741.3M $590.0M
YoY Change 7.33% 13.74%
Depreciation, Depletion And Amortization $992.0K $1.133M
YoY Change 11.84% 39.19%
Cash From Operating Activities $614.6M $543.7M
YoY Change 15.88% 4.16%
INVESTING ACTIVITIES
Capital Expenditures $106.7M $8.558M
YoY Change 986.43% -95.92%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$205.2M -$100.6M
YoY Change -176.6% -92.01%
Cash From Investing Activities -$311.9M -$109.2M
YoY Change -220.84% -92.57%
FINANCING ACTIVITIES
Cash Dividend Paid $434.8M
YoY Change 13.64%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -441.2M -$471.8M
YoY Change 48.3% -147.87%
NET CHANGE
Cash From Operating Activities 614.6M $543.7M
Cash From Investing Activities -311.9M -$109.2M
Cash From Financing Activities -441.2M -$471.8M
Net Change In Cash -138.4M -$37.26M
YoY Change -128.19% -196.17%
FREE CASH FLOW
Cash From Operating Activities $614.6M $543.7M
Capital Expenditures $106.7M $8.558M
Free Cash Flow $507.9M $535.2M
YoY Change -2.42% 71.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1042702763 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1042702763 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
599803000 usd
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilities
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
29579000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
1014713000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
1015330000 usd
CY2024Q1 us-gaap Assets
Assets
44157873000 usd
CY2023Q4 us-gaap Assets
Assets
44059841000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
16711739000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
16724125000 usd
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
186556000 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
227241000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
437766000 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
437599000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
1003254000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
1013102000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
18339315000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
18402067000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1350000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1350000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1043137031 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
10431000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10427000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
1963000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
601365000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
528948000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1562000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1087000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
599803000 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24124875000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24125872000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
156640000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
153870000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1122878000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
965762000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
25414824000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25255931000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
403734000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
401843000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25818558000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25657774000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44157873000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44059841000 usd
CY2024Q1 us-gaap Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
NetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
801200000 usd
CY2024Q1 vici Other Assets Sales Type Subleases Excluding Accrued Interest Allowance For Credit Losses
OtherAssetsSalesTypeSubleasesExcludingAccruedInterestAllowanceForCreditLosses
21000000 usd
CY2023Q4 us-gaap Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
NetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
701100000 usd
CY2023Q4 vici Other Assets Sales Type Subleases Excluding Accrued Interest Allowance For Credit Losses
OtherAssetsSalesTypeSubleasesExcludingAccruedInterestAllowanceForCreditLosses
18700000 usd
CY2024Q1 us-gaap Other Income
OtherIncome
19312000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
18339000 usd
CY2024Q1 vici Income From Golf Operations
IncomeFromGolfOperations
10096000 usd
CY2023Q1 vici Income From Golf Operations
IncomeFromGolfOperations
9845000 usd
CY2024Q1 us-gaap Revenues
Revenues
951481000 usd
CY2023Q1 us-gaap Revenues
Revenues
877647000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16192000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15005000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1133000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
814000 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
19312000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
18339000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6511000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5952000 usd
CY2024Q1 vici Financing Receivable Excluding Accrued Interest Net Investment In Lease And Loans Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestNetInvestmentInLeaseAndLoansCreditLossExpenseReversal
106918000 usd
CY2023Q1 vici Financing Receivable Excluding Accrued Interest Net Investment In Lease And Loans Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestNetInvestmentInLeaseAndLoansCreditLossExpenseReversal
111477000 usd
CY2024Q1 vici Transaction And Acquisition Expense
TransactionAndAcquisitionExpense
305000 usd
CY2023Q1 vici Transaction And Acquisition Expense
TransactionAndAcquisitionExpense
-958000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
150371000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
150629000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1280000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
204882000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
204360000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
5293000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3047000 usd
CY2024Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-156000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
527861000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9787000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9121000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
590016000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10400000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
13641000 usd
CY2024Q1 vici Financing Receivable Excluding Accrued Interest Net Investment In Lease And Loans Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestNetInvestmentInLeaseAndLoansCreditLossExpenseReversal
106918000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
518740000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1042404634 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1001526645 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1043311636 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1003831325 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
599803000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
527861000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
6046000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
6037000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
12482000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-7393000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3644000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1664000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
602595000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
512767000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
9809000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8939000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
592786000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
503828000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25657774000 usd
CY2024Q1 vici Stockholders Equity Reallocation Of Equity
StockholdersEquityReallocationOfEquity
0 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4150
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
440607000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
-1204000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
6046000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
12482000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3644000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25818558000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
22290113000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
527861000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1271472000 usd
CY2023Q1 vici Stockholders Equity Reallocation Of Equity
StockholdersEquityReallocationOfEquity
0 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.3900
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
398688000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
-1129000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
6037000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-7393000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1664000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
599803000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
527861000 usd
CY2024Q1 vici Non Cash Leasing And Financing Adjustments
NonCashLeasingAndFinancingAdjustments
135666000 usd
CY2023Q1 vici Non Cash Leasing And Financing Adjustments
NonCashLeasingAndFinancingAdjustments
122834000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3793000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3467000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1133000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
814000 usd
CY2024Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-156000 usd
CY2023Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
1963000 usd
CY2023Q1 vici Financing Receivable Excluding Accrued Interest Net Investment In Lease And Loans Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestNetInvestmentInLeaseAndLoansCreditLossExpenseReversal
111477000 usd
CY2024Q1 vici Net Proceeds From Derivative Instrument Operating Activities
NetProceedsFromDerivativeInstrumentOperatingActivities
2827000 usd
CY2023Q1 vici Net Proceeds From Derivative Instrument Operating Activities
NetProceedsFromDerivativeInstrumentOperatingActivities
0 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
435000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1280000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3273000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5026000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1380000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-39510000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12282000 usd
CY2024Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-1524000 usd
CY2023Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-1521000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
543739000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
522033000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1266905000 usd
CY2024Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
5900000 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
6100000 usd
CY2024Q1 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
248000 usd
CY2023Q1 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
202683000 usd
CY2024Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
71681000 usd
CY2023Q1 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
209302000 usd
CY2024Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
1100000 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
0 usd
CY2024Q1 vici Payments Of Capitalized Transaction Costs
PaymentsOfCapitalizedTransactionCosts
442000 usd
CY2023Q1 vici Payments Of Capitalized Transaction Costs
PaymentsOfCapitalizedTransactionCosts
220000 usd
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
29579000 usd
CY2023Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
217342000 usd
CY2024Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2410000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
988000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-109160000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1468856000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1272270000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
1028533000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
352704000 usd
CY2024Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
1050000000 usd
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
250000000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2800000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4996000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4595000 usd
CY2024Q1 vici Distributions To Non Controlling Interests
DistributionsToNonControllingInterests
7707000 usd
CY2023Q1 vici Distributions To Non Controlling Interests
DistributionsToNonControllingInterests
2278000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
434811000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
382612000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-471781000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
985489000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-54000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37256000 usd
CY2024Q1 vici Non Cash Dividends Declared Not Paid
NonCashDividendsDeclaredNotPaid
437978000 usd
CY2023Q1 vici Non Cash Dividends Declared Not Paid
NonCashDividendsDeclaredNotPaid
396410000 usd
CY2024Q1 vici Debt Issuance Costs Payable
DebtIssuanceCostsPayable
240000 usd
CY2023Q1 vici Debt Issuance Costs Payable
DebtIssuanceCostsPayable
0 usd
CY2024Q1 vici Deferred Transaction Costs Payable
DeferredTransactionCostsPayable
2896000 usd
CY2023Q1 vici Deferred Transaction Costs Payable
DeferredTransactionCostsPayable
1622000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38740000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
522574000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
208933000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
485318000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247673000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
217967000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
178047000 usd
CY2024Q1 vici Noncash Change In Investment Leases Investing Activities
NoncashChangeInInvestmentLeasesInvestingActivities
71750000 usd
CY2023Q1 vici Noncash Change In Investment Leases Investing Activities
NoncashChangeInInvestmentLeasesInvestingActivities
69621000 usd
CY2024Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
93 property
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from these estimates.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.</span></div>
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
29600000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2024Q1 vici Lessor Leasing Arrangements Sales Type Leases Number Of Renewal Options
LessorLeasingArrangementsSalesTypeLeasesNumberOfRenewalOptions
1 leasearrangement
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk </span></div>Caesars and MGM Resorts International (together with, as the context requires, its subsidiaries, “MGM”) are the guarantors of all the lease payment obligations of the tenants under the applicable leases of the properties that they each respectively lease from us. Revenue from Caesars, which comprises revenue from the Caesars leases, represented 36% and 38% of our lease revenues for the three months ended March 31, 2024 and 2023, respectively. Revenue from MGM, which comprises revenue from the MGM leases, represented 38% and 39% of our lease revenues for the three months ended March 31, 2024 and 2023, respectively. Additionally, our properties on the Las Vegas Strip generated approximately 48% of our lease revenues for each of the three months ended March 31, 2024 and 2023. Other than having two tenants from which we derive and will continue to derive a substantial portion of our revenue and our concentration in the Las Vegas market, we do not believe there are any other significant concentrations of credit risk.
CY2024Q1 vici Loan Portfolio Maximum Prinicipal Amount
LoanPortfolioMaximumPrinicipalAmount
115000000 usd
CY2024Q1 vici Sales Type Lease Number Of Casinos
SalesTypeLeaseNumberOfCasinos
26 casino
CY2024Q1 vici Sales Type Lease Number Of Lease Arrangements
SalesTypeLeaseNumberOfLeaseArrangements
10 leasearrangement
CY2024Q1 vici Financing Receivable Investment In Lease Number Of Casinos
FinancingReceivableInvestmentInLeaseNumberOfCasinos
28 casino
CY2024Q1 vici Financing Receivable Investment In Lease Number Of Lease Arrangements
FinancingReceivableInvestmentInLeaseNumberOfLeaseArrangements
10 leasearrangement
CY2024Q1 vici Financing Receivable Investment In Loans Number Of Loans And Securities
FinancingReceivableInvestmentInLoansNumberOfLoansAndSecurities
16 loan
CY2024Q1 us-gaap Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss
NetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLoss
22985837000 usd
CY2023Q4 us-gaap Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss
NetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLoss
23015931000 usd
CY2024Q1 vici Financing Receivables Operating Leases Net Investment In Lease Before Investment In Loans
FinancingReceivablesOperatingLeasesNetInvestmentInLeaseBeforeInvestmentInLoans
41252549000 usd
CY2023Q4 vici Financing Receivables Operating Leases Net Investment In Lease Before Investment In Loans
FinancingReceivablesOperatingLeasesNetInvestmentInLeaseBeforeInvestmentInLoans
41227033000 usd
CY2024Q1 us-gaap Land Available For Development
LandAvailableForDevelopment
150727000 usd
CY2023Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
150727000 usd
CY2024Q1 us-gaap Real Estate Investments
RealEstateInvestments
42628263000 usd
CY2023Q4 us-gaap Real Estate Investments
RealEstateInvestments
42521937000 usd
CY2024Q1 vici Sales Type Lease And Financing Receivable Unguaranteed Residual Asset
SalesTypeLeaseAndFinancingReceivableUnguaranteedResidualAsset
15800000000 usd
CY2023Q4 vici Sales Type Lease And Financing Receivable Unguaranteed Residual Asset
SalesTypeLeaseAndFinancingReceivableUnguaranteedResidualAsset
15900000000 usd
CY2024Q1 vici Total Lease Revenue Including Contingent Rent
TotalLeaseRevenueIncludingContingentRent
893705000 usd
CY2023Q1 vici Total Lease Revenue Including Contingent Rent
TotalLeaseRevenueIncludingContingentRent
833232000 usd
CY2024Q1 vici Sales Type And Lease Financing Receivable Adjustment
SalesTypeAndLeaseFinancingReceivableAdjustment
-135709000 usd
CY2023Q1 vici Sales Type And Lease Financing Receivable Adjustment
SalesTypeAndLeaseFinancingReceivableAdjustment
-122841000 usd
CY2024Q1 vici Contractual Leasing Revenue
ContractualLeasingRevenue
757996000 usd
CY2023Q1 vici Contractual Leasing Revenue
ContractualLeasingRevenue
710391000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
1264119000 usd
CY2024Q1 vici Financing Receivable To Be Received Remainder Of Fiscal Year
FinancingReceivableToBeReceivedRemainderOfFiscalYear
927821000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Remainder Of Fiscal Year
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedRemainderOfFiscalYear
2191940000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
1712651000 usd
CY2024Q1 vici Financing Receivable To Be Received Due Year One
FinancingReceivableToBeReceivedDueYearOne
1255715000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Due In Twelve Months
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedDueInTwelveMonths
2968366000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
1738942000 usd
CY2024Q1 vici Financing Receivable To Be Received Due Year Two
FinancingReceivableToBeReceivedDueYearTwo
1278993000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Due In Two Years
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedDueInTwoYears
3017935000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
1766012000 usd
CY2024Q1 vici Financing Receivable To Be Received Due Year Three
FinancingReceivableToBeReceivedDueYearThree
1302838000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Due In Three Years
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedDueInThreeYears
3068850000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
1794287000 usd
CY2024Q1 vici Financing Receivable To Be Received Due Year Four
FinancingReceivableToBeReceivedDueYearFour
1327400000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Due In Four Years
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedDueInFourYears
3121687000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears
1823029000 usd
CY2024Q1 vici Financing Receivable To Be Received Due Year Five
FinancingReceivableToBeReceivedDueYearFive
1352442000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Due Year Five
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedDueYearFive
3175471000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
76719989000 usd
CY2024Q1 vici Financing Receivable To Be Received Due Thereafter
FinancingReceivableToBeReceivedDueThereafter
88476087000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Due Thereafter
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedDueThereafter
165196076000 usd
CY2024Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
86819029000 usd
CY2024Q1 vici Financing Receivable To Be Received Due
FinancingReceivableToBeReceivedDue
95921296000 usd
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Due
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedDue
182740325000 usd
CY2024Q1 vici Direct Financing And Sales Type Lease Weighted Average Lease Term
DirectFinancingAndSalesTypeLeaseWeightedAverageLeaseTerm
P37Y8M12D
CY2024Q1 vici Financing Receivable Weighted Average Remaining Lease Term
FinancingReceivableWeightedAverageRemainingLeaseTerm
P48Y6M
CY2024Q1 vici Sales Type And Financing Receivables Lease Receivable To Be Received Weighted Average Lease Term
SalesTypeAndFinancingReceivablesLeaseReceivableToBeReceivedWeightedAverageLeaseTerm
P42Y6M
CY2024Q1 vici Lease Arrangement Number Of Properties
LeaseArrangementNumberOfProperties
93 property
CY2024Q1 vici Lease Arrangement Number Of Lease Agreement
LeaseArrangementNumberOfLeaseAgreement
18 leasearrangement
CY2023Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Chargeoffs
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossChargeoffs
0 usd
CY2024Q1 vici Principal Balance
PrincipalBalance
1248625000 usd
CY2024Q1 vici Financing Receivable Weighted Average Interest Rate
FinancingReceivableWeightedAverageInterestRate
0.090
CY2024Q1 vici Financing Receivable Weighted Average Term
FinancingReceivableWeightedAverageTerm
P4Y9M18D
CY2023Q4 vici Principal Balance
PrincipalBalance
1176111000 usd
CY2023Q4 vici Financing Receivable Weighted Average Interest Rate
FinancingReceivableWeightedAverageInterestRate
0.090
CY2023 vici Financing Receivable Weighted Average Term
FinancingReceivableWeightedAverageTerm
P5Y1M6D
CY2024Q1 us-gaap Net Investment In Lease Excluding Accrued Interest Before Allowance For Credit Loss
NetInvestmentInLeaseExcludingAccruedInterestBeforeAllowanceForCreditLoss
23787027000 usd
CY2024Q1 us-gaap Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
NetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
801190000 usd
CY2024Q1 us-gaap Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss
NetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLoss
22985837000 usd
CY2024Q1 vici Net Investment In Lease Excluding Accrued Interest Allowance For Credit Loss Percentage
NetInvestmentInLeaseExcludingAccruedInterestAllowanceForCreditLossPercentage
0.0337
CY2024Q1 vici Other Assets Sales Type Sub Leases Excluding Accrued Interest Before Allowance For Credit Losses
OtherAssetsSalesTypeSubLeasesExcludingAccruedInterestBeforeAllowanceForCreditLosses
865945000 usd
CY2024Q1 vici Other Assets Sales Type Sub Leases Excluding Accrued Interest After Allowance For Credit Loss
OtherAssetsSalesTypeSubLeasesExcludingAccruedInterestAfterAllowanceForCreditLoss
844936000 usd
CY2024Q1 vici Other Assets Sales Type Sub Leases Excluding Accrued Interest Allowance For Credit Losses Percentage
OtherAssetsSalesTypeSubLeasesExcludingAccruedInterestAllowanceForCreditLossesPercentage
0.0243
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Amortized Cost
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAmortizedCost
44878199000 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest And Off Balance Sheet Credit Loss Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAndOffBalanceSheetCreditLossAllowanceForCreditLoss
1555727000 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAfterAllowanceForCreditLoss
43322472000 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Percentage
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossPercentage
0.0347
CY2023Q4 us-gaap Net Investment In Lease Excluding Accrued Interest Before Allowance For Credit Loss
NetInvestmentInLeaseExcludingAccruedInterestBeforeAllowanceForCreditLoss
23717060000 usd
CY2023Q4 us-gaap Net Investment In Lease Allowance For Credit Loss Excluding Accrued Interest
NetInvestmentInLeaseAllowanceForCreditLossExcludingAccruedInterest
701129000 usd
CY2023Q4 us-gaap Net Investment In Lease Excluding Accrued Interest After Allowance For Credit Loss
NetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLoss
23015931000 usd
CY2023 vici Net Investment In Lease Excluding Accrued Interest Allowance For Credit Loss Percentage
NetInvestmentInLeaseExcludingAccruedInterestAllowanceForCreditLossPercentage
0.0296
CY2023Q4 vici Other Assets Sales Type Sub Leases Excluding Accrued Interest Before Allowance For Credit Losses
OtherAssetsSalesTypeSubLeasesExcludingAccruedInterestBeforeAllowanceForCreditLosses
866052000 usd
CY2023Q4 vici Other Assets Sales Type Sub Leases Excluding Accrued Interest After Allowance For Credit Loss
OtherAssetsSalesTypeSubLeasesExcludingAccruedInterestAfterAllowanceForCreditLoss
847330000 usd
CY2023 vici Other Assets Sales Type Sub Leases Excluding Accrued Interest Allowance For Credit Losses Percentage
OtherAssetsSalesTypeSubLeasesExcludingAccruedInterestAllowanceForCreditLossesPercentage
0.0216
CY2023Q4 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Amortized Cost
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAmortizedCost
44671795000 usd
CY2023Q4 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest And Off Balance Sheet Credit Loss Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAndOffBalanceSheetCreditLossAllowanceForCreditLoss
1453255000 usd
CY2023Q4 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAfterAllowanceForCreditLoss
43218540000 usd
CY2023 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Percentage
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossPercentage
0.0325
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
22400000 usd
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
19100000 usd
CY2023Q4 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLoss
1472386000 usd
CY2022Q4 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLoss
1368819000 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Increase In Current Period Investments
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossIncreaseInCurrentPeriodInvestments
683000 usd
CY2023Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Increase In Current Period Investments
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossIncreaseInCurrentPeriodInvestments
234064000 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Expense Reversal
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossExpenseReversal
105019000 usd
CY2023Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Expense Reversal
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossExpenseReversal
-122774000 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Chargeoffs
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossChargeoffs
0 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossRecovery
0 usd
CY2023Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLossRecovery
0 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLoss
1578088000 usd
CY2023Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Allowance For Credit Loss
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAllowanceForCreditLoss
1480109000 usd
CY2024Q1 vici Financing Receivable Excluding Accrued Interest Net Investment In Lease And Loans Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestNetInvestmentInLeaseAndLoansCreditLossExpenseReversal
106900000 usd
CY2024Q1 vici Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal Loan Originations
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversalLoanOriginations
700000 usd
CY2024Q1 vici Loan Portfolio Maximum Prinicipal Amount
LoanPortfolioMaximumPrinicipalAmount
115000000 usd
CY2023Q1 vici Financing Receivable Excluding Accrued Interest Net Investment In Lease And Loans Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestNetInvestmentInLeaseAndLoansCreditLossExpenseReversal
111500000 usd
CY2023Q1 vici Net Investment In Lease Credit Loss Expense Reversal Current Period Property And Finance Lease Receivable Acquisitions
NetInvestmentInLeaseCreditLossExpenseReversalCurrentPeriodPropertyAndFinanceLeaseReceivableAcquisitions
229600000 usd
CY2023Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
5700000000 usd
CY2023Q1 vici Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal Loan Originations
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversalLoanOriginations
4500000 usd
CY2023Q1 vici Loan Portfolio Maximum Prinicipal Amount
LoanPortfolioMaximumPrinicipalAmount
85000000 usd
CY2024Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Amortized Cost
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAmortizedCost
44878199000 usd
CY2023Q1 vici Financing Receivables Net Investment In Lease And Loans Excluding Accrued Interest Amortized Cost
FinancingReceivablesNetInvestmentInLeaseAndLoansExcludingAccruedInterestAmortizedCost
42723768000 usd
CY2024Q1 vici Sales Type Sub Lease Assets
SalesTypeSubLeaseAssets
844936000 usd
CY2023Q4 vici Sales Type Sub Lease Assets
SalesTypeSubLeaseAssets
847330000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68240000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66946000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36608000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38345000 usd
CY2024Q1 vici Capitalized Real Estate Acquisition Costs
CapitalizedRealEstateAcquisitionCosts
11952000 usd
CY2023Q4 vici Capitalized Real Estate Acquisition Costs
CapitalizedRealEstateAcquisitionCosts
10087000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10564000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11332000 usd
CY2024Q1 us-gaap Other Receivables
OtherReceivables
9965000 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
9660000 usd
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
9689000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
9351000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8997000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9423000 usd
CY2024Q1 vici Tenant Receivables
TenantReceivables
7860000 usd
CY2023Q4 vici Tenant Receivables
TenantReceivables
6236000 usd
CY2024Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4458000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4728000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
1563000 usd
CY2024Q1 vici Other Immaterial Assets
OtherImmaterialAssets
1444000 usd
CY2023Q4 vici Other Immaterial Assets
OtherImmaterialAssets
329000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
1014713000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
1015330000 usd
CY2024Q1 vici Other Assets Sales Type Subleases Excluding Accrued Interest Allowance For Credit Losses
OtherAssetsSalesTypeSubleasesExcludingAccruedInterestAllowanceForCreditLosses
21000000 usd
CY2023Q4 vici Other Assets Sales Type Subleases Excluding Accrued Interest Allowance For Credit Losses
OtherAssetsSalesTypeSubleasesExcludingAccruedInterestAllowanceForCreditLosses
18700000 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
865945000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
866052000 usd
CY2024Q1 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
73600000 usd
CY2023Q4 us-gaap Deferred Long Term Liability Charges
DeferredLongTermLiabilityCharges
73600000 usd
CY2024Q1 vici Operating Lease And Sub Lease Liabilities
OperatingLeaseAndSubLeaseLiabilities
36608000 usd
CY2023Q4 vici Operating Lease And Sub Lease Liabilities
OperatingLeaseAndSubLeaseLiabilities
38345000 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
22361000 usd
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
19131000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4490000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4506000 usd
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
11218000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
250000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
250000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
1003254000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
1013102000 usd
CY2024Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.04364
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
17120140000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
16711739000 usd
CY2023Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.04351
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
17123804000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
16724125000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2050000000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1920140000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1500000000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1600000000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1750000000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
8300000000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
17120140000 usd
CY2023Q4 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.036685
CY2024Q1 vici Operating Lease And Sub Lease Assets
OperatingLeaseAndSubLeaseAssets
36608000 usd
CY2023Q4 vici Operating Lease And Sub Lease Assets
OperatingLeaseAndSubLeaseAssets
38345000 usd
CY2024Q1 vici Operating Lease And Sub Lease Liabilities
OperatingLeaseAndSubLeaseLiabilities
36608000 usd
CY2023Q4 vici Operating Lease And Sub Lease Liabilities
OperatingLeaseAndSubLeaseLiabilities
38345000 usd
CY2024Q1 vici Sales Type Sub Lease Assets
SalesTypeSubLeaseAssets
844936000 usd
CY2023Q4 vici Sales Type Sub Lease Assets
SalesTypeSubLeaseAssets
847330000 usd
CY2024Q1 vici Other Assets Sales Type Subleases Excluding Accrued Interest Allowance For Credit Losses
OtherAssetsSalesTypeSubleasesExcludingAccruedInterestAllowanceForCreditLosses
21000000 usd
CY2023Q4 vici Other Assets Sales Type Subleases Excluding Accrued Interest Allowance For Credit Losses
OtherAssetsSalesTypeSubleasesExcludingAccruedInterestAllowanceForCreditLosses
18700000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1350000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
732000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
498000 usd
CY2024Q1 us-gaap Payments For Rent
PaymentsForRent
713000 usd
CY2023Q1 us-gaap Payments For Rent
PaymentsForRent
473000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
886000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2026000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2772000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2792000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2813000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2835000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
20680000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34804000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19786000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
15018000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y6M
CY2024Q1 vici Common And Preferred Shares Authorized
CommonAndPreferredSharesAuthorized
1400000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1042702763 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
963096563 shares
CY2024Q1 vici Forward Agreement Stock Settled During Period Shares Additional Shares Subject To Forward Sale Agreement
ForwardAgreementStockSettledDuringPeriodSharesAdditionalSharesSubjectToForwardSaleAgreement
0 shares
CY2023Q1 vici Forward Agreement Stock Settled During Period Shares Additional Shares Subject To Forward Sale Agreement
ForwardAgreementStockSettledDuringPeriodSharesAdditionalSharesSubjectToForwardSaleAgreement
40592592 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1043137031 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1004204918 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4150
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.3900
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1042405000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1001527000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
412000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1073000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
495000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
1232000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1043312000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1003831000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
590016000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
518740000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1042405000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1001527000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
590016000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
518740000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1043312000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1003831000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2024Q1 vici Ownership Percentage By Parent
OwnershipPercentageByParent
1
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
30400000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y2M12D
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1043137031 shares

Files In Submission

Name View Source Status
0001705696-24-000080-index-headers.html Edgar Link pending
0001705696-24-000080-index.html Edgar Link pending
0001705696-24-000080.txt Edgar Link pending
0001705696-24-000080-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vici-20240331.htm Edgar Link pending
vici-20240331.xsd Edgar Link pending
vici-20240331_g1.gif Edgar Link pending
viciq12024exh311xviciprope.htm Edgar Link pending
viciq12024exh312xviciprope.htm Edgar Link pending
viciq12024exh313xviciprope.htm Edgar Link pending
viciq12024exh314xviciprope.htm Edgar Link pending
viciq12024exh321xviciprope.htm Edgar Link pending
viciq12024exh322xviciprope.htm Edgar Link pending
viciq12024exh323xviciprope.htm Edgar Link pending
viciq12024exh324xviciprope.htm Edgar Link pending
vici-20240331_lab.xml Edgar Link unprocessable
vici-20240331_htm.xml Edgar Link completed
vici-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
vici-20240331_cal.xml Edgar Link unprocessable
vici-20240331_def.xml Edgar Link unprocessable